U.S. Series B Funding Nears $48 Billion as Deal Counts Fall in 2026

A record funding total with fewer rounds

U.S. Series B funding has reached about $48 billion so far in 2026, its highest level in years. Yet the number of deals trails last year and is on pace for a multiyear low. Those figures tell different stories: the total shows how much capital has gone into the stage, while the deal count shows how broadly that money has been distributed.

Put together, they point to a market where capital is flowing into fewer, larger financings, especially for AI companies. That distinction matters. A strong aggregate can make funding conditions look easier than they are for the typical startup seeking a mid-stage round. The headline is big; the pool of recipients is narrower.

Smaller checks lose ground

Crunchbase data shows that under-$30 million rounds made up less than one-third of the 2026 sample to date. From 2021 through 2025, they accounted for about half of deals. The comparison suggests a marked change in the size mix of reported financings, even as the year is still in progress.

The smallest financings are scarcer still: the sample contains just 26 Series B rounds below $10 million this year. That count gives a sense of how far the bottom of the reported range has thinned. It doesn't, by itself, explain why companies raised less or whether they sought a larger round and couldn't secure one; the data describes completed financings, not the full set of companies looking for capital.

That shift narrows the path for companies seeking a conventional mid-stage raise. A Series B often sits between early proof of a business and the larger scale investors expect at later stages, so the size of available rounds can shape how companies plan hiring, product work, and their next financing. Here's the thing: funding totals can climb even as access becomes more selective, because a limited number of outsized rounds move the aggregate substantially.

Large financings set the pace

At least 110 companies have raised $100 million or more around Series B so far this year, roughly a quarter of reported deals. That concentration helps explain how the total can reach about $48 billion while deal counts lag. When a sizeable share of rounds are unusually large, the aggregate becomes more sensitive to a handful of transactions.

The largest was Prometheus, Jeff Bezos’ physical AI startup, with a $12 billion financing. The company launched last year; its round was described as Series B by multiple reports, though it wasn’t publicly announced under that label. That distinction matters when comparing stages: round labels can reflect reporting and company descriptions, and the figures here include some financings classified by their characteristics.

World Labs, the model developer led by Fei-Fei Li, raised $1 billion in February. Valar Atomics, a nuclear energy startup, also secured $1 billion in Series B funding across tranches this year, with Sequoia Capital leading. These deals show the scale of capital available to some companies, but a few prominent examples can't establish the terms available to the wider group of startups.

The figures include rounds with Series B characteristics that weren’t explicitly announced as such. The deal sample covers U.S. Series B financings of at least $1 million. Those boundaries help define what the totals represent, but they also mean the number depends in part on how rounds are classified and which financings are included.

AI dominates capital and deal flow

AI-focused startups have received about two-thirds of Series B funding so far in 2026, compared with roughly half of the investment in 2025. They account for more than half of reported U.S. Series B deals as well, making AI the clearest driver of both the higher funding total and the market’s concentration.

The gap between AI’s share of funding and its share of deals points to larger rounds in the category. It doesn't mean every AI company is raising easily, or that every non-AI startup is shut out. It does show that the category is carrying a substantial share of reported Series B dollars, so changes in a relatively small set of large AI financings could shift the overall total.

My read is that investors are rewarding AI companies that can show traction and have already raised substantial seed and Series A capital. That leaves a tougher market for startups looking for smaller Series B checks, even as headline funding suggests a strong year for the stage. The numbers here are underwhelming for breadth. The key measure to watch is whether deal volume broadens beyond the largest AI financings.

What the pattern could mean next

This is more significant than it looks: the funding total alone doesn't tell you whether the market is healthy for companies across the stage. Deal count and round size add essential context. If you're working in this space, the useful comparison is not simply whether Series B dollars are up, but whether companies with different profiles are still completing rounds and whether smaller financings regain a meaningful share.

And yet, one year-to-date snapshot can't settle that question. The figures could change as more rounds are reported, and the classification of some deals adds another layer of uncertainty. (And this is the part most people overlook.) A rising total can coexist with a difficult fundraising process for many companies, because capital concentrated in a few large rounds doesn't automatically travel to the rest of the market.

For now, the data supports a narrower conclusion: reported Series B funding is unusually high, while deal activity is weaker and AI accounts for a large share of both dollars and rounds. Whether that pattern broadens will determine how representative the headline total becomes. Not every company gets the same market.

Related Crunchbase query

• US Series B Funding, 2026

Illustration: Dom Guzman